Creating Targeted Therapeutics Utilising Exosomes

A consulting company in translational and clinical Biomarkers field with more than 20+ years of experience. Successful track record of transitioning research and preclinical programs to Phase I, II and full approval.

Co-founder and Vice President

Led Experimental Pathology group, supported biologics and small molecule oncology portfolio, streamlined operations, ensured excellence achieved in all procedures undertaken by the group, provided critical pathology input for pipeline projects, interfaced with local and global stakeholders across 4 sites, provided directives and reviewed performance of 4 direct reports.

• Study Pathologist for GLP and SOP-compliant studies. Provided specialist knowledge, technical expertise, and training in interpretive gross and histopathology • Directed GLP and non-GLP pre-clinical and histopathology (TCR, IHC) studies• Designed, conducted and interpreted investigative toxicology studies to characterize and investigate the mechanism of toxic changes of candidate drugs.• Oversaw necropsy conduct and provided training and assistance to prosectors• Chaired CBI Safety Committee and served as a Member of CBI IACUC. Responsibilities included: directing facility inspections as well as authorship and editorial review on multiple IACUC protocols and SOPs• Designed and developed new microscopy and immunohistochemistry techniques, implemented new areas of service, helped establish new animal models• Leadership role in design and conduct of investigative pathology research projects• Interacted with multidisciplinary group of Study Directors, provides significant input in design and conduct of mechanistic studies• Part of management team, influential in decision making process, supervises research associates and technicians of histology/immunohistochemistry and pharamacology/toxicology groups

• Conducted necropsies and provided diagnostic services to the clients of State Animal Health Diagnostic Laboratory• Investigated new or poorly understood diseases, with emphasis on use of histopathological interpretation• Compiled numerous histopathology reports • Provided professional consulting and liaising with clients, industry bodies, and groups on a broad range of animal health matters

• Characterized genetically-modified mouse models using light, immunofluorescent, confocal laser scanning, and transmission electron microscopy• Performed ultrastructural studies of contractile and non-contractile elements of skeletal and cardiac muscle• Performed functional in vivo imaging of mitochondria via dual-photon microscopy• Provided professional advice on histopathology and microscopy-related matters, including purchase of new equipment